Total Payments
$1.4M
2024 Payments
$743,914
Companies
21
Transactions
1,072
Medicare Patients
44,516
Medicare Billing
$13.8M
Payment Breakdown by Category
Other$1.3M (91.2%)
Travel$82,935 (5.9%)
Consulting$20,667 (1.5%)
Food & Beverage$19,739 (1.4%)
Education$206.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $705,721 | 235 | 50.3% |
| Debt forgiveness | $573,060 | 1 | 40.8% |
| Travel and Lodging | $82,935 | 226 | 5.9% |
| Consulting Fee | $20,667 | 7 | 1.5% |
| Food and Beverage | $19,739 | 596 | 1.4% |
| Honoraria | $800.00 | 1 | 0.1% |
| Education | $206.59 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Skye Orthobiologics LLC | $573,060 | 1 | $0 (2024) |
| ABBVIE INC. | $303,867 | 423 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $184,301 | 185 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $109,089 | 65 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $99,766 | 208 | $0 (2024) |
| GENZYME CORPORATION | $91,630 | 82 | $0 (2024) |
| Janssen Biotech, Inc. | $30,753 | 52 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $10,079 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $184.62 | 13 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $89.06 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $743,914 | 141 | Skye Orthobiologics LLC ($573,060) |
| 2023 | $188,926 | 275 | Regeneron Healthcare Solutions, Inc. ($67,802) |
| 2022 | $156,991 | 217 | Regeneron Healthcare Solutions, Inc. ($44,603) |
| 2021 | $93,089 | 110 | Janssen Scientific Affairs, LLC ($65,003) |
| 2020 | $61,509 | 81 | Novartis Pharmaceuticals Corporation ($48,110) |
| 2019 | $93,589 | 121 | AbbVie, Inc. ($48,370) |
| 2018 | $34,100 | 65 | AbbVie, Inc. ($34,069) |
| 2017 | $31,009 | 62 | AbbVie, Inc. ($30,972) |
All Payment Transactions
1,072 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,875.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2024 | Skye Orthobiologics LLC | — | Debt forgiveness | Cash or cash equivalent | $573,060.00 | General |
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $40.75 | General |
| Category: Immunology | ||||||
| 10/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $14,338.00 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $970.06 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $408.96 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $292.67 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $128.09 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,875.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 5,462 | 18,459 | $3.7M | $1.8M |
| 2022 | 73 | 12,814 | 40,252 | $9.1M | $4.7M |
| 2021 | 82 | 16,080 | 50,530 | $9.5M | $5.5M |
| 2020 | 64 | 10,160 | 23,320 | $3.2M | $1.7M |
Total Patients
44,516
Total Services
132,561
Medicare Billing
$13.8M
Procedure Codes
267
All Medicare Procedures & Services
267 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 185 | 3,558 | $1.4M | $753,213 | 52.9% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 201 | 3,634 | $970,880 | $512,011 | 52.7% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 184 | 3,440 | $209,046 | $110,068 | 52.7% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 177 | 486 | $138,200 | $72,580 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 790 | 938 | $126,141 | $50,197 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 457 | 581 | $111,845 | $43,435 | 38.8% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 149 | 494 | $62,856 | $33,434 | 53.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 201 | 272 | $69,437 | $33,070 | 47.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 448 | 498 | $75,723 | $29,275 | 38.7% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 44 | 77 | $45,153 | $23,600 | 52.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 262 | 296 | $50,288 | $20,227 | 40.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 442 | 487 | $48,664 | $15,188 | 31.2% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 173 | 288 | $28,189 | $14,970 | 53.1% |
| 77285 | Obtaining data needed to develop the optimal radiation treatment, 2 treatment areas | Office | 2023 | 30 | 30 | $19,009 | $10,295 | 54.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 183 | 253 | $18,895 | $9,755 | 51.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 168 | 168 | $27,993 | $8,673 | 31.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 322 | 1,711 | $17,060 | $7,857 | 46.1% |
| 77261 | Simple radiation therapy planning | Office | 2023 | 130 | 136 | $14,312 | $7,480 | 52.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $17,010 | $6,885 | 40.5% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 27 | 34 | $14,072 | $6,774 | 48.1% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 18 | 18 | $12,473 | $6,312 | 50.6% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 17 | 17 | $11,399 | $6,091 | 53.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 29 | 31 | $13,744 | $6,067 | 44.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 17 | $10,614 | $5,020 | 47.3% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 102 | 158 | $9,246 | $4,744 | 51.3% |
About Alpesh Desai
Alpesh Desai is a Dermatology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386696904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alpesh Desai has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $743,914 received in 2024. These payments were reported across 1,072 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($705,721).
As a Medicare-enrolled provider, Desai has provided services to 44,516 Medicare beneficiaries, totaling 132,561 services with total Medicare billing of $13.8M. Data is available for 4 years (2020–2023), covering 267 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Specialist
- Location Houston, TX
- Active Since 05/16/2006
- Last Updated 09/09/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1386696904
Products in Payments
- DUPIXENT (Biological) $218,700
- TREMFYA (Drug) $139,734
- SKYRIZI (Biological) $133,916
- COSENTYX (Biological) $99,365
- Humira (Biological) $48,349
- Skyrizi (Biological) $35,212
- RINVOQ (Biological) $33,428
- Odomzo (Drug) $8,954
- HUMIRA (Biological) $7,581
- ODOMZO (Drug) $800.00
- COSENTYX (Drug) $276.26
- Sotyktu (Drug) $184.62
- BLU-U (Medical Supply) $115.70
- REMICADE (Biological) $107.36
- XTRAC (Device) $48.81
- ADBRY (Biological) $29.25
- Otezla (Drug) $28.18
- EUCRISA (Drug) $23.13
- Cimzia (Drug) $21.98
- VALCHLOR (Drug) $21.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Houston
Dr. Michael Migden, Md, MD
Dermatology — Payments: $379,143
Dermatology $379,143
Dr. Geeta Patel, D.o, D.O
Dermatology — Payments: $341,210
Dermatology $341,210
Catherine Papasakelariou, M.d, M.D
Dermatology — Payments: $270,262
Dermatology $270,262
Megan Couvillion, Md, MD
Dermatology — Payments: $154,211
Dermatology $154,211
Suzanne Bruce, M.d, M.D
Dermatology — Payments: $135,195
Dermatology $135,195
Dr. Jennifer Deaver, Md, MD
Dermatology — Payments: $132,895
Dermatology $132,895